New benzimidazole derivative as a selective RORgamma inverse agonist for prostate cancer treatment Aug. 31, 2021
New dual orexin receptor agonists for the treatment of orexin-deficient disorders such as narcolepsy Aug. 25, 2021
Small-molecule degrader targets phospho-AKT and inhibits growth of PI3K/PTEN pathway mutant cancers Aug. 24, 2021
RSS